Skip to main content

Table 2 Corticosteroid Use and Status in US Males with Duchenne Muscular Dystrophy under the Age of 35, and US Males with Becker Muscular Dystrophy Enrolled in The Duchenne Registry

From: Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry

 

Duchenne

Becker

Population

All

Ambulatoryb

Nonambulatoryb

All

Males with Duchenne Muscular Dystrophy n, (%)

N = 1538

N = 845

N = 569

N = 154

Currently using corticosteroids

969 (63.0)

604 (71.5)

277 (48.7)

30 (19.5)

Deflazacort a

524 (54.1) a

344 (57.0) a

132 (47.7) a

21 (70.0) a

Prednisone/prednisolone a

445 (45.9) a

260 (43.0) a

145 (52.3) a

9 (30.0) a

Never used corticosteroids

381 (24.8)

223 (26.3)

131 (23.0)

115 (74.6)

Used to take corticosteroids

188 (12.2)

18 (2.1)

161 (28.3)

9 (5.8)

  1. aPercentages were calculated from number of males currently using corticosteroids as the denominator
  2. bNot all respondents provided ambulatory status